Clinical Trial Update: Coronary Flow Reserve in Patients With Bio-active Stent or Everolimus-eluting Stent Implanted in Acute Coronary Syndrome

View source ↗

Summary

This completed clinical trial evaluated coronary flow reserve in patients with acute coronary syndrome who received either a bio-active stent or an everolimus-e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Bio-Active-stent
• Everolimus-eluting stent (everolimus-eluting stent)

Snippet

Sponsor: The Hospital District of Satakunta | Conditions: Acute Coronary Syndrome | Status: COMPLETED